These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25025430)

  • 1. Gene expression profiling of the response to interferon beta in Epstein-Barr-transformed and primary B cells of patients with multiple sclerosis.
    Khsheibun R; Paperna T; Volkowich A; Lejbkowicz I; Avidan N; Miller A
    PLoS One; 2014; 9(7):e102331. PubMed ID: 25025430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte subpopulations, oxidative burst and apoptosis in peripheral blood cells of patients with multiple sclerosis-effect of interferon-beta.
    Mix E; Stefan K; Höppner J; Klauer T; Zettl UK; Strauss U; Meyer-Rienecker HJ; Rolfs A
    Autoimmunity; 2003 Aug; 36(5):291-305. PubMed ID: 14567559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-beta increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity.
    Krumbholz M; Faber H; Steinmeyer F; Hoffmann LA; Kümpfel T; Pellkofer H; Derfuss T; Ionescu C; Starck M; Hafner C; Hohlfeld R; Meinl E
    Brain; 2008 Jun; 131(Pt 6):1455-63. PubMed ID: 18474519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.
    Hecker M; Hartmann C; Kandulski O; Paap BK; Koczan D; Thiesen HJ; Zettl UK
    Mol Neurobiol; 2013 Dec; 48(3):737-56. PubMed ID: 23636981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of EBV transformation on gene expression levels and methylation profiles.
    Caliskan M; Cusanovich DA; Ober C; Gilad Y
    Hum Mol Genet; 2011 Apr; 20(8):1643-52. PubMed ID: 21289059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis.
    Hong J; Zang YC; Hutton G; Rivera VM; Zhang JZ
    J Neuroimmunol; 2004 Jul; 152(1-2):126-39. PubMed ID: 15223245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence from genome wide association studies implicates reduced control of Epstein-Barr virus infection in multiple sclerosis susceptibility.
    Afrasiabi A; Parnell GP; Fewings N; Schibeci SD; Basuki MA; Chandramohan R; Zhou Y; Taylor B; Brown DA; Swaminathan S; McKay FC; Stewart GJ; Booth DR
    Genome Med; 2019 Apr; 11(1):26. PubMed ID: 31039804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAFF is a biological response marker to IFN-beta treatment in multiple sclerosis.
    Gandhi KS; McKay FC; Schibeci SD; Arthur JW; Heard RN; Stewart GJ; Booth DR
    J Interferon Cytokine Res; 2008 Sep; 28(9):529-39. PubMed ID: 18715196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Lee DH; Park KS; Kong ID; Kim JW; Han BG
    BMC Immunol; 2006 Sep; 7():22. PubMed ID: 16970829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance.
    Hundeshagen A; Hecker M; Paap BK; Angerstein C; Kandulski O; Fatum C; Hartmann C; Koczan D; Thiesen HJ; Zettl UK
    J Neuroinflammation; 2012 Jun; 9():140. PubMed ID: 22727118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cell type-specific transcriptomic approach to map B cell and monocyte type I interferon-linked pathogenic signatures in Multiple Sclerosis.
    Severa M; Rizzo F; Srinivasan S; Di Dario M; Giacomini E; Buscarinu MC; Cruciani M; Etna MP; Sandini S; Mechelli R; Farina A; Trivedi P; Hertzog PJ; Salvetti M; Farina C; Coccia EM
    J Autoimmun; 2019 Jul; 101():1-16. PubMed ID: 31047767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of immune cell trafficking in interferon-beta treated multiple sclerosis patients.
    Hartrich L; Weinstock-Guttman B; Hall D; Badgett D; Baier M; Patrick K; Feichter J; Hong J; Ramanathan M
    J Neuroimmunol; 2003 Jun; 139(1-2):84-92. PubMed ID: 12799025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Monotonically Differentially Expressed Genes for IFN-
    Tian S; Zhang L
    Biomed Res Int; 2019; 2019():5647902. PubMed ID: 31915697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statin-induced changes in gene expression in EBV-transformed and native B-cells.
    Bolotin E; Armendariz A; Kim K; Heo SJ; Boffelli D; Tantisira K; Rotter JI; Krauss RM; Medina MW
    Hum Mol Genet; 2014 Mar; 23(5):1202-10. PubMed ID: 24179175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients.
    Giacomini E; Severa M; Rizzo F; Mechelli R; Annibali V; Ristori G; Riccieri V; Salvetti M; Coccia EM
    Eur J Immunol; 2013 Jul; 43(7):1963-72. PubMed ID: 23636665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential gene expression and translational approaches to identify biomarkers of interferon beta activity in multiple sclerosis.
    Croze E
    J Interferon Cytokine Res; 2010 Oct; 30(10):743-9. PubMed ID: 20874251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis.
    Rizzo F; Giacomini E; Mechelli R; Buscarinu MC; Salvetti M; Severa M; Coccia EM
    Immunol Cell Biol; 2016 Oct; 94(9):886-894. PubMed ID: 27265253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of new sensitive biomarkers for the in vivo response to interferon-beta treatment in multiple sclerosis using DNA-array evaluation.
    Sellebjerg F; Krakauer M; Hesse D; Ryder LP; Alsing I; Jensen PE; Koch-Henriksen N; Svejgaard A; Soelberg Sørensen P
    Eur J Neurol; 2009 Dec; 16(12):1291-8. PubMed ID: 19558503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.
    Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA
    Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.